Upload
Featured Recent Articles Topics Login Upload

Search Results for 'months relapsed'

months relapsed published presentations and documents on DocSlides.

Relapsed and Refractory Myeloma
Relapsed and Refractory Myeloma
by jane-oiler
Ruben Niesvizky. Myeloma Center. Myelomacenter.or...
Novel
Novel
by tatiana-dople
Agents . for . Indolent . L. ymphoma . and . Mant...
Future directions: Can we improve outcomes in relapsed/refractory DLBCL or aggressive NHL?
Future directions: Can we improve outcomes in relapsed/refractory DLBCL or aggressive NHL?
by mitsue-stanley
Bertrand Coiffier. Service d. ’. Hématologie. ...
Recurrent Follicular Lymphoma
Recurrent Follicular Lymphoma
by sherrill-nordquist
With a Short First Remission:. How Aggressive Sho...
Pivotal Safety and Efficacy Results From TRANSCEND NHL 001, a Multicenter Phase 1 Study of Lisocabtagene Maraleucel in Relapsed/Refractory (R/R) Large B-Cell Lymphomas
Pivotal Safety and Efficacy Results From TRANSCEND NHL 001, a Multicenter Phase 1 Study of Lisocabtagene Maraleucel in Relapsed/Refractory (R/R) Large B-Cell Lymphomas
by botgreat
Lisocabtagene. . Maraleucel. in Relapsed/Refract...
Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone in Relapsed or Ref
Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone in Relapsed or Ref
by willow
Meletios Dimopoulos,. 1. Hang Quach,. 2. Maria-V...
x0000x0000 xAttxachexd xBottxom xBBoxx
x0000x0000 xAttxachexd xBottxom xBBoxx
by evans
Chimeric Antigen Receptor Tcell TherapyClinical Gu...
CAR-T Therapy in non-Hodgkin lymphomas
CAR-T Therapy in non-Hodgkin lymphomas
by natalie
Jonathon B. Cohen, MD. Dept of . Hematology. /Medi...